Liquid Biopsy perspectives theranostics and personalized oncology
<p>The current limitations of cancer diagnosis and molecular profiling based on invasive tissue biopsies or clinical imaging have led to the development of the Liquid Biopsy field (LB), includes the isolation of Circulating Tumor Cells (CTCs), circulating free or tumor DNA (cfDNA or ctDNA), Ex...
Saved in:
Main Author: | C Daniel Ascencio González (Author) |
---|---|
Format: | Book |
Published: |
Annals of Cytology and Pathology - Peertechz Publications,
2020-09-14.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advanced Theranostic Nanomedicine in Oncology
Published: (2020) -
Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology
by: Karama Asleh, et al.
Published: (2023) -
Nanoparticles as a Tool in Neuro-Oncology Theranostics
by: Andrea L. Klein, et al.
Published: (2021) -
Liquid Biopsy
Published: (2019) -
Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response
Published: (2020)